Saturday, April 05, 2014 1:49:08 PM
Mcet is the most advanced biotech company which uses mrna technology to cure liver cancer. If they can show similar results in phase 2b as in phase 2a, Pfizer will buy them out for at least .3000 dollar/share (1-1.5 billion dollar). For now a fair value is 10% of that, worth .0300 dollar/share.
Sentiment: Strong Buy
Good post from the Yahoo Finance board.
http://finance.yahoo.com/mbview/threadview/?&bn=ab116216-adca-32a3-b056-c6907bc35e82&tid=1396697142711-3dfb554b-1ad9-4d41-8426-42408c10274b&tls=la%2Cd%2C0%2C3
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM